China Nepstar Chain Drugstore Ltd (NPD) Reports In-Line Q3 EPS

China Nepstar Chain Drugstore Ltd (NYSE: NPD) reported Q3 EPS of ($0.02), in-line with the analyst estimate of ($0.02).

Revenue for the third quarter of 2014 increased by 8.1% to RMB738.3 million (US$120.3million) from RMB683.2 million for the same period in 2013. Same store sales (for the 1,847 stores opened before December 31, 2012 and which were operating as of September 30, 2014) for the third quarter of 2014 increased by 8.1% compared to the same period in 2013. The increase in revenue and same store sales was primarily due to in-store promotional initiatives and marketing efforts for pharmaceutical products.

For earnings history and earnings-related data on China Nepstar Chain Drugstore Ltd (NPD) click here.

You May Also Be Interested In

• Wells Fargo upgrades S&P 500 Industrials to favorable
• Cboe stock surges 5% on S&P 500 licensing deal extension
• AT&T and Corning sign $3B fiber supply agreement